The catalytic phosphoinositol 3-kinase isoform p110δ is required for glioma cell migration and invasion

European Journal of Cancer

Volumn 48, Issue 1, 2012, Pages 149-157

  Luk, Sze Ki ^a   Piekorz, Roland P ^b   Nürnberg, Bernd ^c   Tony To, Shing Shun ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Glioma; Invasion; Migration; P110 ; Phosphoinositide 3 kinase

Indexed keywords

FOCAL ADHESION KINASE; ISOENZYME; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN CDC42; PROTEIN P110DELTA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENZYME MECHANISM; GLIOBLASTOMA; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL LINE;

BRAIN NEOPLASMS; CATALYTIC DOMAIN; CDC42 GTP-BINDING PROTEIN; CELL MOVEMENT; CELLS, CULTURED; CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE; FOCAL ADHESION KINASE 1; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GLIOMA; HUMANS; ISOENZYMES; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING;

EID: 83255193930     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.09.006     Document Type: Article

References (48)

1. B. Vanhaesebroeck, S.J. Leevers, and K. Ahmadi Synthesis and function of 3-phosphorylated inositol lipids Annu Rev Biochem 70 2001 535 602
2. P.A. Steck, M.A. Pershouse, and S.A. Jasser Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers Nat Genet 15 1997 356 362
3. Y. Tohma, C. Gratas, and W. Biernat PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas J Neuropathol Exp Neurol 57 1998 684 689
4. P.T. Hawkins, K.E. Anderson, and K. Davidson Signalling through Class I PI3Ks in mammalian cells Biochem Soc Trans 34 2006 647 662
5. R. Marone, V. Cmiljanovic, and B. Giese Targeting phosphoinositide 3-kinase: moving towards therapy Biochim Biophys Acta 1784 2008 159 185
6. R. Katso, K. Okkenhaug, and K. Ahmadi Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer Annu Rev Cell Dev Biol 17 2001 615 675
7. U. Maier, A. Babich, and B. Nürnberg Roles of non-catalytic subunits in gbetagamma-induced activation of class I phosphoinositide 3-kinase isoforms beta and gamma J Biol Chem 274 1999 29311 29317
8. C. Brock, M. Schaefer, and HP. Reusch Roles of G beta gamma in membrane recruitment and activation of p110 gamma/p101 phosphoinositide 3-kinase gamma J Cell Biol 160 2003 89 99
9. B. Kurig, A. Shymanets, and T. Bohnacker Ras is an indispensable coregulator of the class IB phosphoinositide 3-kinase p87/p110gamma Proc Natl Acad Sci USA 106 2009 20312 20317
10. B. Vanhaesebroeck, M.J. Welham, and K. Kotani p110delta, a novel phosphoinositide 3-kinase in leukocytes Proc Natl Acad Sci USA 94 1997 4330 4335
11. B.J. Eickholt, A.I. Ahmed, and M. Davies Control of axonal growth and regeneration of sensory neurons by the p110delta PI 3-kinase PLoS ONE 2007 2:e869
12. C. Sawyer, J. Sturge, and DC. Bennett Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta Cancer Res 63 2003 1667 1675
13. A. Arcaro, U.K. Khanzada, and B. Vanhaesebroeck Two distinct phosphoinositide 3-kinases mediate polypeptide growth factor-stimulated PKB activation EMBO J 21 2002 5097 5108
14. D. Boller, A. Schramm, and K.T. Doepfner Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells Clin Cancer Res 14 2008 1172 1181
15. J.W. Lee, Y.H. Soung, and S.Y. Kim PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas Oncogene 24 2005 1477 1480
16. Y. Samuels, L.A. Diaz Jr, and O. Schmidt-Kittler Mutant PIK3CA promotes cell growth and invasion of human cancer cells Cancer Cell 7 2005 561 573
17. H.J. An, N.H. Cho, and H.S. Yang Targeted RNA interference of phosphatidylinositol 3-kinase p110-beta induces apoptosis and proliferation arrest in endometrial carcinoma cells J Pathol 212 2007 161 169
18. C. Adamson, O.O. Kanu, and A.I. Mehta Glioblastoma multiforme: a review of where we have been and where we are going Expert Opin Investig Drugs 18 2009 1061 1083
19. F. Lefranc, J. Brotchi, and R. Kiss Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance to migrating glioblastoma cells to apoptosis J Clin Oncol 23 2005 2411 2422
20. R. Stupp, M.E. Hegi, and W.P. Mason Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 2009 459 466
21. F. Lefranc, V. Facchini, and R. Kiss Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas Oncologist 12 2007 1395 1403
22. S.A. Woods, C.J. McGlade, and A. Guha Phosphatidylinositol 3′-kinase and MAPK/ERK kinase 1/2 differentially regulate expression of vascular endothelial growth factor in human malignant astrocytoma cells Neuro-oncol 4 2002 242 252
23. K. Yu, J. Lucas, and T. Zhu PWT-458, a novel pegylated-17- hydroxywortmannin, inhibits phosphatidylinositol 3-kinase signaling and suppresses growth of solid tumors Cancer Biol Ther 4 2005 538 545
24. S.I. Gharbi, M.J. Zvelebil, and S.J. Shuttleworth Exploring the specificity of the PI3K family inhibitor LY294002 Biochem J 404 2007 15 21
25. C. Billottet, V.L. Grandage, and RE. Gale A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16 Oncogene 25 2006 6648 6659
26. N.T. Ihle, and G. Powis Inhibitors of phosphatidylinositol-3-kinase in cancer therapy Mol Aspects Med 31 2010 135 144
27. N. Kim, A. Saudemont, and L. Webb The p110delta catalytic isoform of PI3K is a key player in NK-cell development and cytokine secretion Blood 110 2007 3202 3208
28. K. Ali, M. Camps, and WP. Pearce Isoform-specific functions of phosphoinositide 3-kinases: p110 delta but not p110 gamma promotes optimal allergic responses in vivo J Immunol 180 2008 2538 2544
29. S. Beer-Hammer, and E. Zebedin The catalytic PI3K isoforms p110gamma and p110delta contribute to B cell development and maintenance, transformation, and proliferation J Leukoc Biol 87 2010 1083 1095
30. P. Sujobert, V. Bardet, and P. Cornillet-Lefebvre Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia Blood 106 2005 1063 1066
31. L. Zhao, and P.K. Vogt Class I PI3K in oncogenic cellular transformation Oncogene 27 2008 5486 5496
32. A. Ridley Molecular switches in metastasis Nature 406 2000 466 467
33. J.M. Mataraza, M.W. Briggs, and Z. Li IQGAP1 promotes cell motility and invasion J Biol Chem 278 2003 41237 41245
34. H.R. Reiske, S.C. Kao, and L.A. Cary Requirement of phosphatidylinositol 3-kinase in focal adhesion kinase-promoted cell migration J Biol Chem 274 1999 12361 12366
35. J.D. Hood, and D.A. Cheresh Role of integrins in cell invasion and migration Nat Rev Cancer 2 2002 91 100
36. M. Natarajan, T.P. Hecker, and C.L. Gladson FAK signaling in anaplastic astrocytoma and glioblastoma tumors Cancer J 9 2003 126 133
37. J. Ling, Z. Liu, and D. Wang Malignant astrocytoma cell attachment and migration to various matrix proteins is differentially sensitive to phosphoinositide 3-OH kinase inhibitors J Cell Biochem 73 1999 533 544
38. F.M. Vega, and A.J. Ridley Rho GTPases in cancer cell biology FEBS Lett 582 2008 2093 2101
39. B. Salhia, F. Rutten, and M. Nakada Inhibition of Rho-kinase affects astrocytoma morphology, motility and invasion through activation of Rac1 Cancer Res 65 2005 8792 8800
40. A.Y. Chan, S.J. Coniglio, and Y.Y. Chuang Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion Oncogene 24 2005 7821 7829
41. G.G. Zhai, R. Malhotra, and M. Delaney Radiation enhances the invasive potential of primary glioblastoma cells via activation of the Rho signaling pathway J Neurooncol 76 2006 227 237
42. P.T. Hawkins, A. Eguinoa, and R.G. Qiu PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase Curr Biol 5 1995 393 403
43. M. Nakagawa, M. Fukata, and M. Yamaga Recruitment and activation of Rac1 by the formation of E-cadherin-mediated cell-cell adhesion sites J Cell Sci 114 2001 1829 1838
44. V. Benard, B.P. Bohl, and G.M. Bokoch Characterization of rac and cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases J Biol Chem 274 1999 13198 13204
45. K. Stengel, and Y. Zheng Cdc42 in oncogenic transformation, invasion, and tumorigenesis Cell Signal 23 2011 1415 1423
46. R. Rathinam, A. Berrier, and S.K. Alahari Role of Rho GTPases and their regulators in cancer progression Front Biosci 17 2011 2561 2571
47. F. Lefranc, S. James, and I. Camby Combined cimetidine and temozolomide, compared with temozolomide alone: significant increases in survival in nude mice bearing U373 human glioblastoma multiforme orthotopic xenografts J Neurosurg 102 2005 706 714
48. V. Megalizzi, V. Mathieu, and T. Mijatovic 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs Neoplasia 9 2007 358 369